View:     View:
tid Target Cancers General Effect on Target
Name
Source
Type

Ubiquitin-conjugating enzyme E2 C is a protein that in humans is encoded by the UBE2C gene. UBE2C is upregulated in 28 different cancers. UBE2C expression is significantly higher in late-stage tumors. Silencing UBE2C arrests cell cycle progression at the G 1 /S phases, inhibits cell proliferation in pancreatic ductal adenocarcinoma and blocks the G 2 /M transition in melanoma.

UBE2C is most frequently overexpressed in a wide array of cancers compared to their normal tissue counterparts.
– High UBE2C expression is consistently associated with aggressive tumor features, advanced disease, and reduced overall survival.




(Will delete Record if Target field = "Delete")
 Home